Advertisement
News
Advertisement

Novavax says it is a contender for contract

Thu, 04/22/2010 - 5:17am
The Associated Press

Biotechnology company Novavax Inc. said Thursday that it is a contender with the Department of Health and Human Services for a flu contract.

The company is developing new vaccines for swine flu and for other flu strains and respiratory diseases, products that are several years away from reaching the market.

Shares of Novavax rose 18 cents, or 7.2 percent, to $2.69 in premarket trading.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading